BackRegeneron Pharmaceuticals Overview

Regeneron Pharmaceuticals Net Income

Profitability analysis for REGN.

Quarterly Net Income

$727.20M
↓ 10.08% YoY

As of Mar 2026

Annual Net Income (TTM)

$4.42B
↓ 1.69% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin